SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-014640
Filing Date
2024-02-13
Accepted
2024-02-13 17:00:35
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20231231.htm   iXBRL 10-Q 1237097
2 EX-3.2 meip-ex3_2.htm EX-3.2 52565
3 EX-10.4 meip-ex10_4.htm EX-10.4 113907
4 EX-31.1 meip-ex31_1.htm EX-31.1 14662
5 EX-31.2 meip-ex31_2.htm EX-31.2 14545
6 EX-32.1 meip-ex32_1.htm EX-32.1 8582
7 GRAPHIC img104086284_0.jpg GRAPHIC 77977
8 GRAPHIC img104086284_1.jpg GRAPHIC 45116
9 GRAPHIC img104086284_2.jpg GRAPHIC 94371
10 GRAPHIC img267926920_0.jpg GRAPHIC 4141
  Complete submission text file 0000950170-24-014640.txt   6997269

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20231231.xsd EX-101.SCH 1111428
75 EXTRACTED XBRL INSTANCE DOCUMENT meip-20231231_htm.xml XML 1052359
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41827 | Film No.: 24627554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)